Building on the achievements of this study, future work will incorporate multicellular cultures—including endothelial cells, astrocytes, and pericytes—under dynamic culture conditions to enable a more comprehensive analysis of GBM progression and evaluate potential chemotherapeutic strategies targeting the AR-HSP27 axis. This evidence concerns the gene AR and glioblastoma.